SETD1B and hepatocellular carcinoma: Finally, our analysis of public databases revealed that elevated expression and stemness of the genes SETD1B, CD24, and N-cadherin were significantly correlated with poorer prognosis in HCC patients' post-treatment (Figure 8H).